Crewe Advisors’s Medpace MEDP Stock Holding History

Crewe Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$2.81K	–	1102
2025 Q4	$2.81K	Buy	+5	New	+$2.84K	﹤0.01%	824
2024 Q2	–	Sell	-9	Closed	-$3.64K	–	1000
2024 Q1	$3.64K	Buy	+9	New	+$3.16K	﹤0.01%	786

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Crewe Advisors's MEDP Position: Q1 2026 in Review

Crewe Advisors sold out of Medpace (MEDP) in Q1 2026, closing a stake of 5 shares — an estimated $2.81K sold.

Crewe Advisors first reported a position in MEDP in Q1 2024 and held it in 2 quarters. The position peaked at $3.64K in Q1 2024. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Crewe Advisors reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Crewe Advisors sold 5 Medpace shares in Q1 2026, an estimated $2.81K.
Crewe Advisors first reported a position in Medpace in Q1 2024 and held it in 2 quarters.
Crewe Advisors's Medpace position peaked at $3.64K in Q1 2024.
733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Crewe Advisors's 13F filing for Q1 2026, filed 7 May 2026.